| Acid Phosphatase |
ACP-001-PWD-0100 |
10 x 10 mL |
· |
Normal Range: 2.5 to 11.4 U/L |
| · |
Increased levels in metastasized prostate |
| · |
Increased levels with Paget's disease, hyperparathyroidism with skeletal involvement and in cancers which have invaded the bone. |
|
Alanine Aminotransferase |
ALT-002-LIQ-0150 |
R1-120 mL
R2-30 mL |
· |
Normal Range: 4 to 36 U/L |
| · |
Increased levels with hepatic necrosis such as cirrhosis, carcinoma, viral or toxic hepatitis, and obstructive jaundice. |
| · |
Increased levels with extensive trauma and muscle disease, circulatory failure, shock, hypoxia, myocardial infarction, and hemolytic disease. |
|
Albumin
Albumin Standard |
ALB-003-LIQ-0120
ALB-0016-LIQ-STD |
120 mL15 mL |
· |
Normal Range: 3.5 to 5.3 g/dL |
| · |
Increased levels with dehydration. |
| · |
Decreased levels with liver disease, nephrotic syndrome, malnutrition and protein-losing enteropathies. |
|
| Alkaline Phosphatase |
ALP-004-LIQ-0150 |
R1-120 mL
R2-30 mL |
· |
Normal Range: 33 to 123 U/L |
| · |
Increased levels with liver and bone disease. |
| · |
Moderate elevations with Hodgkin's disease, congestive heart failure, Fanconi's syndrome, hyperparathyroidism, intestinal disease, and intra-abdominal bacterial infections. |
|
| Ammonia |
AMN-005-PWD-0085 |
R1-10 x 6.5 mL
R2-10 x 2 mL |
· |
Normal Range: 11 to 35 mmol/L |
| · |
Increased levels with Reye's syndrome, other forms of liver cell damage and impending hepatic coma. |
|
| Amylase |
AMY-006-LIQ-0120 |
4 x 30 mL |
· |
Normal Range: 35 to 140 U/mL |
| · |
Increased levels with acute pancreatitis, pancreatic duct obstruction, intra-abdominal disease, mumps, and bacterial parotitis. |
|
| Aspartate Aminotransferase |
AST-007-LIQ-0150 |
R1-120 mL
R2-30 mL |
· |
Normal Range: 5 to 34 U/L |
| · |
Increased levels with damage or disease to heart, liver, skeletal muscle, and kidney tissues such as myocardial infarction, viral hepatitis, liver necrosis, cirrhosis and muscular dystrophy. |
|
Bilirubin, Direct
Bilirubin, Total
Bilirubin, Calibrator |
BIL-008-LIQ-0120
BIL-009-LIQ-0120
BIL-0017-LIQ-CAL |
R1-120 mL R2-15 mL
R1-120 mL R2-15 mL
5 x 3 mL |
· |
Normal Range: Total = 0.2 to 1.2 mg/dL |
| · |
Normal Range: Direct = 0 to 0.3 mg/dL |
| · |
Increased levels of total bilirubin associated with liver disease and hemolytic disorders. |
| · |
Increased levels of conjugated (Direct) bilirubin associated with biliary obstruction and hepatocellular disease. |
|
BUN (Urea Nitrogen)
BUN Standard |
BUN-010-LIQ-0150
BUN-0025-LIQ-STD |
150 mL
15 mL |
· |
Normal Range: 7 to 18 mg/dL |
| · |
Increased levels with renal disease, dehydration, diabetic coma, hypoadrenal crisis, gastrointestinal hemorrhage and circulatory collapse. |
| · |
Decreased levels with severe liver disease. |
|
Calcium, Arsenazo III
Calcium Standard |
CAL-011-LIQ-0120
CAL-0028-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 8.5 to 10.0 mg/dL |
| · |
Increased levels with hyperparathyroidism, metastatic bone lesions and hypervitaminosis D. |
| · |
Decreased levels with hypoparathyroidism, rickets, steatorrhea, nephritic and calcium-losing syndromes. |
|
Chloride
Chloride Standard |
CHL-012-LIQ-0120
CHL-0030-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 98 to 106 mEq/L |
| · |
Decreased levels with gastrointestinal or salt-losing nephritis, Addison's disease and metabolic acidosis. |
| · |
Increased levels with dehydration, nephritis, renal obstruction, congestive heart failure and Cushing's syndrome. |
|
Cholesterol
Cholesterol Calibrator
Cholesterol Standard |
CHO-013-LIQ-0120
CHO-0012-LIQ-CAL
CHO-0012-LIQ-STD |
120 mL
10 x 5 mL
15 mL |
· |
Desired Range < 200 mg/dL |
| · |
Borderline High: 200 to 239 mg/dL |
| · |
High > 240 mg/dL |
| · |
Indicator of liver function, intestinal absorption, risk of coronary heart disease, thyroid function and adrenal disease. |
|
| Creatine Kinase |
CKN-014-LIQ-0150 |
R1-120 mL
R2- 30 mL |
· |
Normal Range: 1 to 160 U/L |
| · |
Increased levels with myocardial infarction 4 to 6 hours after onset of pain and peaking at 18 to 30 hours. |
| · |
Above normal levels with muscular dystrophy, hyperthyroidism, pulmonary infarction and acute cardiovascular disease. |
|
Creatinine
Creatinine Standard |
CRT-015-LIQ-0150
CRT-0018-LIQ-STD |
R1-120 mL R2- 30 mL
15 mL |
· |
Normal Range: 0.4 to 1.4 mg/dL |
| · |
Increased levels with substantially impaired renal function. |
|
| Gamma Glutamyl Transferase |
GGT-016-LIQ-0150 |
R1-120 mL
R2- 30 mL |
· |
Normal Range: 8 to 54 U/L |
| · |
Increased levels with chronic alcoholism, liver disease, myocardial infarction with secondary liver damage, brain lesions and Dilantin therapy. |
|
Glucose, Oxidase
Glucose, Standard |
GLU-017-LIQ-0120
GLU-0019-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 70 to 107 mg/dL |
| · |
Increased levels with diabetes mellitus, hyperactive pituitary or adrenal glands. |
| · |
Decreased levels with insulin secreting tumors, myxedema, hypopituitarism, hypoadrenalism and abnormal glucose adsorption. |
|
Hemoglobin
Hemoglobin Control
Hemoglobin Standard |
HEM-018-LIQ-0120
HEM-0020-LIQ-CTL
HEM-0020-LIQ-STD |
120 mL
3 x 2 mL
2 mL |
· |
Normal Range: 11 to 18 g/dL |
| · |
Increased values with polycythemia or dehydration. |
| · |
Decreased values with anemia. |
|
High Density Cholesterol
HDL Standard
Lipid Control Set |
HDL-019-LIQ-0060
HDL-0013-LIQ-STD
HDL-0013-LIQ-CTL |
2 x 30 mL
15 mL
6 x 3 mL |
· |
Desired Range > 35 mg/dL |
| · |
Decreased levels associated with increased risk of coronary heart disease or other atherosclerotic complications. |
|
| Lactate Dehydrogenase |
LDH-021-LIQ-0150 |
R1-120 mL
R2-30 mL |
· |
Normal Range: 80 to 285 U/L |
| · |
Increased levels with myocardial infarction 8 to 12 hours after onset of pain with peak values at 4 to 5 days. |
| · |
Moderate increase with liver disease, untreated pernicious anemia, renal disease, malignancy and muscular dystrophy. |
|
Magnesium
Magnesium Standard |
MAG-023-LIQ-0135
MAG-0032-LIQ-STD |
R1-120 mL R2-15 mL
15 mL |
· |
Normal Range: 1.3 to 2.5 mEq/L |
| · |
Increased levels with uremia. |
| · |
Decreased levels with malabsorption, treatment of diabetic coma, postoperative patients receiving intravenous fluids, chronic and acute alcoholism, chronic renal disease, congestive heart failure, pancreatitis, lupus erythematosus and hyperthyroidism. |
|
| Microprotein |
MIP-024-LIQ-0240 |
R1-120 mL
R2-15 mL |
· |
For the determination of total protein in urine specimens |
| · |
Indicator of renal disorders. |
|
Phosphorus
Phosphorus Standard |
PHO-025-LIQ-0120
PHO-0033-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 2.4 to 4.8 mg/dL |
| · |
Increased levels with chronic nephritis, hypoparathyroidism, hypervitaminosis D. |
| · |
Decreased levels with rickets, osteomalacia, hyperparathyroidism and during treatment of diabetic coma. |
|
| Potassium |
POT-026-LIQ-0120 |
120 mL |
· |
Normal Range: 3.4 to 5.3 mEq/L |
| · |
Elevated levels (hyperkalemia) with renal failure, dehydration, shock and adrenal insufficiency (Addison's disease). |
| · |
Decreased levels with malnutrition, negative nitrogen balance, gastrointestinal fluid losses and hyper-activity of the adrenal cortex (Cushing's Syndrome). |
|
Protein, Tota
Protein, Standard |
PRO-027-LIQ-0120
PRO-0022-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 6.2 to 8.5 g/dL |
| · |
Increased levels with dehydration or increase in one of more globular fractions. |
| · |
Decreased levels with low albumin levels. |
|
| Sodium |
SOD-028-LIQ-0120 |
R1-120 mL
R2-120 mL |
· |
Normal Range: 135 to 155 mEq/L |
| · |
Increased levels with excess water loss, hypergluco- or mineralocorticoidism and inadequate water intake. |
| · |
Decreased levels with increased water uptake and dilutional hyponatremia due to cardiac failure, liver failure, nephrotic syndrome or malnutrition. |
|
Triglycerides
Triglycerides Standard |
TRI-029-LIQ-0120
TRI-0015-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 44 to 148 mg/dL |
| · |
Increased levels with nephrotic syndrome, coronary heart disease, hypothyroidism, diabetes mellitus and liver disease. |
| · |
Decreased levels with protein malnutrition, abetalipoproteinemia, hyperthyroidism and cachectic states. |
|
Uric Acid
Uric Acid Standard |
URI-030-LIQ-0120
URI-0026-LIQ-STD |
120 mL
15 mL |
· |
Normal Range: 2.5 to 7.7 mg/dL |
| · |
Increased levels with gout, leukemia, polycythemia, familial idiopathic hyperuricemia, and conditions associated with decreased renal function. |
|
| Chemistry Calibrator |
CHE-0099-PWD-CAL |
10 x 5 mL |
· |
Lyophilized human serum intended for the calibration of quantitative clinical chemistry assays. |
| · |
Defined assay values for 20 tests. |
|
| Chemistry Control Level 1 |
CHE-0099-PWD-CTL |
10 x 5 mL |
· |
Lyophilized human serum intended for the verification of quantitative clinical chemistry assays. |
| · |
Level 1 Controls have assay levels within the normal range. |
| · |
Defined assay value ranges for 35 tests. |
|
| Chemistry Control Level 2 |
CHE-0099-PWD-CTL2 |
10 x 5 mL |
· |
Lyophilized human serum intended for the verification of quantitative clinical chemistry assays. |
| · |
Level 2 Controls have assay levels outside of the normal range. |
| · |
Defined assay value ranges for 35 tests. |